Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.38 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19004134 | 1.00 | ACHE (0.50) | ACHETDP1CYP2D6CYP2C9HPGD | |
| SCHEMBL17469595 | 1.00 | ACHE (0.50) | ACHETDP1CYP2D6CYP2C9HPGD | |
| SCHEMBL10068159 | 0.92 | ACHE (0.42) | ACHETDP1CYP2D6CYP2C9HPGD | |
| SCHEMBL158 | 0.90 | — | — | |
| SCHEMBL2757577 | 0.90 | — | — | |
| SCHEMBL17078009 | 0.87 | — | — | |
| Bromide SCHEMBL3346674 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL11574766 | 0.87 | — | — | |
| Fluoride SCHEMBL752726 | 0.87 | ACHE (0.57) | ACHETDP1ALDH1A1CA1CA2 | |
| SCHEMBL10634092 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114085300-B | Modified polybutadiene resin and preparation method and application thereof | 南亚新材料科技股份有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-114085300-A | Modified polybutadiene resin and preparation method and application thereof | 南亚新材料科技股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| WO-2024035622-A1 | INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS | BELLBROOK LABS, LLC (US) | 2024-02-15 | — | — | WO | disclosed |
| US-20240023434-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20230312481-A1 | SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF | ARBUTUS BIOPHARMA CORP (CA) | 2023-10-05 | — | — | US | disclosed |
| WO-2023181962-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, AND IMAGE DISPLAY DEVICE | 三菱ケミカル株式会社 | 2023-09-28 | — | — | WO | disclosed |
| CN-114085300-B | Modified polybutadiene resin and preparation method and application thereof | 南亚新材料科技股份有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-11744146-B2 | Amine-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-29 | — | — | US | disclosed |
| US-11732138-B2 | Deep ultraviolet-excitable water-solvated polymeric dyes | BECTON, DICKINSON AND COMPANY (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230235177-A1 | Deep Ultraviolet-Excitable Water-Solvated Polymeric Dyes | BECTON, DICKINSON AND COMPANY | 2023-07-27 | — | — | US | disclosed |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-5160487-A | Tetraarylbenzidine derivative as charge transport compound | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1992-11-03 | — | — | US | disclosed |
| EP-0475676-A1 | Electrophotographic member | HITACHI CHEMICAL CO., LTD. (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-4898800-A | DURABILITY | RICOH COMPANY, LTD. (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0119067-B1 | PROCESS FOR PREPARING ALDEHYDES | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1986-11-26 | — | — | EP | disclosed |
| US-4607116-A | FROM DIARYLIODONIUM SALT | NIPPON PETROCHEMICALS COMPANY LIMITED (JP) | 1986-08-19 | — | — | US | disclosed |
| EP-0119065-B1 | PROCESS FOR PREPARING DIARYLS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1986-08-13 | — | — | EP | disclosed |
| US-4590281-A | REACTING DIARYLIODONIUM SALT WITH UNSATURATED ALCOHOL | NIPPON PETROCHEMICALS COMPANY (JP) | 1986-05-20 | — | — | US | disclosed |
| EP-0119065-A1 | Process for preparing diaryls | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-09-19 | — | — | EP | disclosed |
| EP-0119067-A1 | Process for preparing aldehydes | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | ACHE 1136/4885TDP1 3142/4885CYP2D6 634/4885 |
| US-11744146-B2 | Amine-based compound and organic light-emitting device including the same | AOC2, AOC1, EML4 | ACHE 37/4885TDP1 1125/4885CYP2D6 2096/4885 |
| US-20230312481-A1 | SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF | NSD3, PML, NSD1 | ACHE 4527/4885TDP1 3167/4885CYP2D6 2178/4885 |
| US-20240023434-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OCIAD2, AOX1 | ACHE 2015/4885TDP1 4217/4885CYP2D6 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.